Ms. Sarna is founder and former CEO of nVision Medical, acquired by Boston Scientific (NYSE: BSX), a CHV I portfolio company. Darshana has known Surbhi since 2011 and was the lead investor in and board member of nVision until 2018. Surbhi is a board member of Penumbra (NYSE: PEN) where she serves on both the audit and nominating committees. Additionally, she is a board member of Astia, which has both a nonprofit arm and a venture fund that serves women entrepreneurs, and is a board member of the Harker School and Draper University. Currently, Surbhi is taking a hiatus from running her own company. Instead, she derives great joy from advising and mentoring first-time startup CEOs through various organizations such as the Fogarty Institute, Y-Combinator, and the Ferolyn Fellowship. She has recently become the first Group Partner focused on healthcare and biotech at Y-Combinator.